Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension. (Q51310737)
Jump to navigation
Jump to search
scientific article published on 14 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension. |
scientific article published on 14 January 2015 |
Statements
Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension (English)
S-M Jin
S W Park
K-H Yoon
K W Min
K-H Song
K S Park
J-Y Park
I B Park
S H Baik
S H Choi
H W Lee
I-K Lee
D-M Kim
14 January 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference